Analysts Anticipate Colgate-Palmolive (NYSE:CL) Will Announce Earnings of $0.71 Per Share

Wall Street brokerages expect Colgate-Palmolive (NYSE:CL) to announce earnings per share (EPS) of $0.71 for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Colgate-Palmolive’s earnings, with the lowest EPS estimate coming in at $0.70 and the highest estimate coming in at $0.71. Colgate-Palmolive reported earnings per share of $0.72 during the same quarter last year, which would suggest a negative year-over-year growth rate of 1.4%. The company is scheduled to issue its next quarterly earnings results on Friday, October 25th.

On average, analysts expect that Colgate-Palmolive will report full year earnings of $2.84 per share for the current year, with EPS estimates ranging from $2.83 to $2.85. For the next financial year, analysts forecast that the company will post earnings of $3.06 per share, with EPS estimates ranging from $3.00 to $3.13. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research firms that cover Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 26th. The company reported $0.72 EPS for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The firm had revenue of $3.87 billion for the quarter, compared to analysts’ expectations of $3.88 billion. During the same period in the prior year, the firm posted $0.77 earnings per share. The company’s quarterly revenue was down .5% on a year-over-year basis.



A number of equities research analysts have recently commented on CL shares. Piper Jaffray Companies started coverage on Colgate-Palmolive in a research note on Tuesday, August 13th. They issued an “overweight” rating on the stock. Morgan Stanley increased their target price on Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 target price on the stock. in a research note on Friday, June 7th. Argus increased their target price on Colgate-Palmolive from $72.00 to $82.00 and gave the stock a “buy” rating in a research note on Tuesday, June 11th. Finally, Citigroup increased their target price on Colgate-Palmolive from $77.00 to $79.00 and gave the stock a “neutral” rating in a research note on Tuesday. One analyst has rated the stock with a sell rating, twelve have given a hold rating and six have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $73.87.

In other news, insider Prabha Parameswaran sold 5,000 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $69.35, for a total transaction of $346,750.00. Following the transaction, the insider now directly owns 20,893 shares of the company’s stock, valued at $1,448,929.55. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Ian M. Cook sold 19,500 shares of the company’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $69.92, for a total value of $1,363,440.00. Following the transaction, the insider now directly owns 1,186,042 shares in the company, valued at $82,928,056.64. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 564,285 shares of company stock worth $40,530,290. Corporate insiders own 1.14% of the company’s stock.

Large investors have recently made changes to their positions in the company. Parsec Financial Management Inc. increased its position in Colgate-Palmolive by 0.5% in the second quarter. Parsec Financial Management Inc. now owns 30,081 shares of the company’s stock worth $2,156,000 after buying an additional 146 shares in the last quarter. Heritage Way Advisors LLC increased its position in Colgate-Palmolive by 0.4% in the second quarter. Heritage Way Advisors LLC now owns 33,769 shares of the company’s stock worth $2,420,000 after buying an additional 146 shares in the last quarter. Tiemann Investment Advisors LLC increased its position in Colgate-Palmolive by 2.4% in the first quarter. Tiemann Investment Advisors LLC now owns 6,455 shares of the company’s stock worth $442,000 after buying an additional 150 shares in the last quarter. Moloney Securities Asset Management LLC grew its position in shares of Colgate-Palmolive by 2.7% during the second quarter. Moloney Securities Asset Management LLC now owns 6,038 shares of the company’s stock worth $433,000 after purchasing an additional 157 shares in the last quarter. Finally, Lynch & Associates IN grew its position in shares of Colgate-Palmolive by 0.6% during the first quarter. Lynch & Associates IN now owns 28,930 shares of the company’s stock worth $1,983,000 after purchasing an additional 160 shares in the last quarter. 75.83% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE CL traded down $0.81 during trading on Friday, reaching $72.23. The company had a trading volume of 2,972,789 shares, compared to its average volume of 3,701,071. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $76.41. The stock has a market cap of $61.97 billion, a PE ratio of 24.32, a P/E/G ratio of 4.67 and a beta of 0.76. The business’s 50-day moving average is $72.56 and its 200 day moving average is $70.11. The company has a quick ratio of 0.78, a current ratio of 1.13 and a debt-to-equity ratio of 32.25.

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Thursday, July 18th were issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.38%. The ex-dividend date of this dividend was Wednesday, July 17th. Colgate-Palmolive’s payout ratio is currently 57.91%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Further Reading: Why do companies issue convertible shares?

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.